Abstract
Introduction: Cerebral palsy (CP) after brain injury in children is associated with velocity dependent muscle stiffness and motor function impairment. Continuous intrathecal baclofen (cITB) is established for children with CP but the implantation of a baclofen pump is reserved for patients with severe symptoms refractory to oral drug management or with adverse side effects (ASEs) under high oral baclofen doses. The advantages of cITB are a low dose, a low rate of ASEs and improved muscle relaxation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
